 |
|
Effects of NMDA Receptor Antagonists: Implications for the Pathophysiology of Schizophrenia
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
We appreciate the interest of Drs Shim and Adityanjee in the mechanistic
implications of our study, which described the interactive effects of lamotrigine
and ketamine in healthy human subjects.1
They question whether reductions in N-methyl-D-aspartate
receptor (NMDAR) function produced by ketamine in fact enhance regional glutamatergic
neurotransmission via non-NMDARs. Because of this concern, they question whether
lamotrigine reduces the hyperglutamatergic effects of ketamine or whether
it attenuates ketamine's effects through other mechanisms. In response to
these queries, it is important to point out that the study in question is
quite limited in its capacity to determine how lamotrigine attenuates ketamine's
effects. The fact that lamotrigine reduced the psychotogenic and cognitive
effects of ketamine, but potentiated the euphoric effects of ketamine, may
have mechanistic significance. For example, it suggests that lamotrigine is
not simply antagonizing the effects of ketamine at the NMDAR. Preclinical
research may provide insight into the interactive . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Revealing Past Memories: Proactive Interference and Ketamine-Induced Memory Deficits
Chrobak et al.
J. Neurosci. 2008;28:4512-4520.
ABSTRACT
| FULL TEXT
Dysfunctional Neural Plasticity in Patients With Schizophrenia
Daskalakis et al.
Arch Gen Psychiatry 2008;65:378-385.
ABSTRACT
| FULL TEXT
Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions
Corlett et al.
Brain 2007;130:2387-2400.
ABSTRACT
| FULL TEXT
Targeting Prefrontal Cortical Dopamine D1 and N-Methyl-D-Aspartate Receptor Interactions in Schizophrenia Treatment
Yang and Chen
Neuroscientist 2005;11:452-470.
ABSTRACT
|
